PPJE (PPJ Healthcare Enterprises) 3-Year RORE % : 0.00% (As of Dec. 2009)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PPJ Healthcare Enterprises 3-Year RORE %?

PPJ Healthcare Enterprises PPJE -98.00% 3-Year RORE % is 0.00 as of Dec. 2009.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. PPJ Healthcare Enterprises's 3-Year RORE % for the quarter that ended in Dec. 2009 was 0.00%.

The industry rank for PPJ Healthcare Enterprises's 3-Year RORE % or its related term are showing as below:

PPJE's 3-Year RORE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.07
* Ranked among companies with meaningful 3-Year RORE % only.

PPJ Healthcare Enterprises  (OTCPK:PPJE) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


PPJ Healthcare Enterprises 3-Year RORE % Related Terms


PPJ Healthcare Enterprises 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for PPJ Healthcare Enterprises's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PPJ Healthcare Enterprises 3-Year RORE % Chart

PPJ Healthcare Enterprises Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
3-Year RORE %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

PPJ Healthcare Enterprises Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
3-Year RORE % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

PPJE vs LOGQ, MDFI, NMXS: 3-Year RORE % Comparison

For the Health Information Services subindustry, PPJ Healthcare Enterprises's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PPJ Healthcare Enterprises 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PPJ Healthcare Enterprises's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where PPJ Healthcare Enterprises's 3-Year RORE % falls into.



PPJ Healthcare Enterprises 3-Year RORE % Calculation

PPJ Healthcare Enterprises's 3-Year RORE % for the quarter that ended in Dec. 2009 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( - )/( -10000-0 )
=/-10000
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2009 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 0.00 mean?
PPJ Healthcare Enterprises (PPJE) has a 3-Year RORE % of 0.00 as of Dec. 2009. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on PPJ Healthcare Enterprises and its competitors.
Is PPJ Healthcare Enterprises' 3-Year RORE % too high?
PPJ Healthcare Enterprises' current 3-Year RORE % is 0.00.
How does PPJ Healthcare Enterprises' 3-Year RORE % compare to LOGQ and MDFI?
PPJ Healthcare Enterprises' 3-Year RORE % of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-Year RORE % is 0.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.07, based on 603 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on PPJ Healthcare Enterprises and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PPJ Healthcare Enterprises's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PPJ Healthcare Enterprises stock overvalued right now?
PPJ Healthcare Enterprises (PPJE) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For PPJ Healthcare Enterprises (PPJE), the current 3-Year RORE % is 0.00 as of Dec. 2009. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PPJ Healthcare Enterprises Business Description

Address 402 Jackson Street, Suite 2340, Tampa, FL, USA, 33602
PPJ Healthcare Enterprises Inc engages in joint venturing with doctors in setting up new practices, marketing, and management of pain management practices and blood culture labs. The company also engages in the development and testing of medical marijuana, medical cannabis products, and medical billing specialties in anesthesiology. The projects of the company include automated biller, medical billing service, pain management center, and Lab testing.